Keith Ward
Board Member
Skye Bioscience, Inc. (SKYE)Equibles does not estimate personal net worth.
Get an email with a short summary when Skye Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get SKYE alertsAbout Keith Ward
Keith Ward is recorded as Board Member at Skye Bioscience, Inc. (SKYE) since December 14, 2021. Skye Bioscience, Inc. reported in an 8-K filed December 20, 2021 that Keith Ward was appointed director, effective December 14, 2021. Skye Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Skye Bioscience, Inc. includes Lisa Anson (CEO), Punit Dhillon (CEO, Chief Accounting Officer and Board Member), Paul Grayson (Chairman and Board Member) and 7 others.
“On December 14, 2021, the Board of Directors (the “Board”) of Skye Bioscience, Inc., a Nevada corporation (the “Company”) increased the size of the Board from four to five directors and elected Dr. Keith Ward, Ph.D. to fill such vacancy and serve as a director until his successor is duly elected or appointed and qualified or until his earlier retirement, disqualification resignation, removal or death.”
Affiliation history
-
Current
2021-12-14–present
Company network
Leadership on record at Skye Bioscience, Inc.
- Lisa Anson CEO
- Punit Dhillon CEO, Chief Accounting Officer, Board Member
- Paul Grayson Chairman, Board Member
- Elena Traistaru CFO
- Kaitlyn Arsenault CFO
- Peter Collum CFO
- Tu Diep COO
- Dr. Cliff Jones CTO
- Andrew J. Schwab Board Member
- Andrew Schwab Board Member